Cargando…
Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate
Introduction. The aim of this study was to show the long-term clinical outcomes of implants placed in maxillary sinus floor augmentation (MFSA) using beta-tricalcium phosphate (β-TCP). Patients and methods. Maxillary patients were diagnosed for MFSA and used beta- β-TCP. After the lateral sinus surg...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508221/ https://www.ncbi.nlm.nih.gov/pubmed/34639277 http://dx.doi.org/10.3390/ijerph18199975 |
_version_ | 1784582044480700416 |
---|---|
author | Velasco-Ortega, Eugenio Sierra-Baztan, Angela Jiménez-Guerra, Alvaro España-López, Antonio Ortiz-Garcia, Iván Núñez-Márquez, Enrique Moreno-Muñoz, Jesús Rondón-Romero, José Luis López-López, José Monsalve-Guil, Loreto |
author_facet | Velasco-Ortega, Eugenio Sierra-Baztan, Angela Jiménez-Guerra, Alvaro España-López, Antonio Ortiz-Garcia, Iván Núñez-Márquez, Enrique Moreno-Muñoz, Jesús Rondón-Romero, José Luis López-López, José Monsalve-Guil, Loreto |
author_sort | Velasco-Ortega, Eugenio |
collection | PubMed |
description | Introduction. The aim of this study was to show the long-term clinical outcomes of implants placed in maxillary sinus floor augmentation (MFSA) using beta-tricalcium phosphate (β-TCP). Patients and methods. Maxillary patients were diagnosed for MFSA and used beta- β-TCP. After the lateral sinus surgery, implants were loaded at 6 months with restorations. The clinical follow-up was at 10 years. Results. One hundred and one patients (58 females and 43 males) were treated with MFSA. Twenty-nine patients (28.7%) had a history of periodontitis. Thirty-three patients (32.7%) were smokers. One hundred and twenty-one MFSA, 81 unilateral and 20 bilateral sites, with 234 implants were performed. The average vertical bone height available was 4.92 ± 1.83 mm. The average vertical bone gain obtained was 6.95 ± 2.19 mm following MFSA. The implant cumulative survival rate was 97.2%. Three implants (1.3%) were lost during the healing period. Six implants (2.6%) were lost by peri-implantitis. One hundred and fifteen restorations were placed in the patients. Mean marginal bone loss was 1.93 mm ± 1.03 mm. Six patients (27.3%) showed technical complications. Thirty-six implants (15.3%) in 14 patients (13.9%) were associated with peri-implantitis. Conclusions. This study indicates that treatment with implant-supported restoration by MFSA using β-TCP constitutes a successful implant approach. |
format | Online Article Text |
id | pubmed-8508221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85082212021-10-13 Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate Velasco-Ortega, Eugenio Sierra-Baztan, Angela Jiménez-Guerra, Alvaro España-López, Antonio Ortiz-Garcia, Iván Núñez-Márquez, Enrique Moreno-Muñoz, Jesús Rondón-Romero, José Luis López-López, José Monsalve-Guil, Loreto Int J Environ Res Public Health Article Introduction. The aim of this study was to show the long-term clinical outcomes of implants placed in maxillary sinus floor augmentation (MFSA) using beta-tricalcium phosphate (β-TCP). Patients and methods. Maxillary patients were diagnosed for MFSA and used beta- β-TCP. After the lateral sinus surgery, implants were loaded at 6 months with restorations. The clinical follow-up was at 10 years. Results. One hundred and one patients (58 females and 43 males) were treated with MFSA. Twenty-nine patients (28.7%) had a history of periodontitis. Thirty-three patients (32.7%) were smokers. One hundred and twenty-one MFSA, 81 unilateral and 20 bilateral sites, with 234 implants were performed. The average vertical bone height available was 4.92 ± 1.83 mm. The average vertical bone gain obtained was 6.95 ± 2.19 mm following MFSA. The implant cumulative survival rate was 97.2%. Three implants (1.3%) were lost during the healing period. Six implants (2.6%) were lost by peri-implantitis. One hundred and fifteen restorations were placed in the patients. Mean marginal bone loss was 1.93 mm ± 1.03 mm. Six patients (27.3%) showed technical complications. Thirty-six implants (15.3%) in 14 patients (13.9%) were associated with peri-implantitis. Conclusions. This study indicates that treatment with implant-supported restoration by MFSA using β-TCP constitutes a successful implant approach. MDPI 2021-09-22 /pmc/articles/PMC8508221/ /pubmed/34639277 http://dx.doi.org/10.3390/ijerph18199975 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Velasco-Ortega, Eugenio Sierra-Baztan, Angela Jiménez-Guerra, Alvaro España-López, Antonio Ortiz-Garcia, Iván Núñez-Márquez, Enrique Moreno-Muñoz, Jesús Rondón-Romero, José Luis López-López, José Monsalve-Guil, Loreto Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate |
title | Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate |
title_full | Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate |
title_fullStr | Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate |
title_full_unstemmed | Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate |
title_short | Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate |
title_sort | long-term clinical study of implants placed in maxillary sinus floor augmentation using beta-tricalcium phosphate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508221/ https://www.ncbi.nlm.nih.gov/pubmed/34639277 http://dx.doi.org/10.3390/ijerph18199975 |
work_keys_str_mv | AT velascoortegaeugenio longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT sierrabaztanangela longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT jimenezguerraalvaro longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT espanalopezantonio longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT ortizgarciaivan longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT nunezmarquezenrique longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT morenomunozjesus longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT rondonromerojoseluis longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT lopezlopezjose longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate AT monsalveguilloreto longtermclinicalstudyofimplantsplacedinmaxillarysinusflooraugmentationusingbetatricalciumphosphate |